ABOUT
Built to Accelerate the Fight Against Cancer
At Niowave, we understand the weight of what we do. Every isotope delivered supports a therapy already in motion, and depends on a supply that is consistent, controlled, and reliable.
Our responsibility and mission is to meet this need. Not only through production, but across the systems needed to maintain quality, build scale, and ensure delivery.
We are building the infrastructure that patients and next-generation therapies depend on. From Actinium-225 to emerging isotopes, our work will scale to support where oncology therapies are heading.
Our Technology, Our Advantage
Niowave’s approach to isotope production is built on direct control of the technologies and processes involved.
We design, build, and operate our own superconducting linear accelerators, and pair them with in-house radiochemistry and processing capabilities. This structure allows the full production workflow, from irradiation through final isotope distribution, to be managed within a single system.
Maintaining that control reduces dependency on external equipment, timelines, and supply chains, and allows for continuous improvement as production demands evolve.
The result is a production environment that can be refined over time and adapted to support both current needs and future isotope development.
Our People, Our Culture
None of our work is possible without the team behind it.
At Niowave, we are building a team of people who care about the impact of their work and the mission that drives it. Every day, scientists, engineers, technicians, operators and business professionals come together to solve complex problems in support of cancer treatment and the future of radiopharmaceutical medicine.
The work is challenging, fast-moving, and highly collaborative. Success requires people who are willing to step in, take ownership, learn continuously, and support one another through difficult problems.
Our culture is grounded in teamwork, integrity, courage, and upright zeal. These values shape how we work together, approach challenges, and continue improving as individuals and as a company.
As we continue to grow, we are looking for mission-driven people who want to do meaningful work alongside teams that are committed to making a real difference for patients.
Built for What’s Next
The continued advancement of targeted cancer therapies depends on infrastructure capable of growing alongside it. Isotope supply must support increasing demand while maintaining consistency, quality, and regulatory control. Niowave is building toward that requirement through the technology we develop, the teams we build, and the commitment to carry that work forward. Our vision is to ensure that isotope supply is ready to support the therapies moving through development today and those that will follow.